资源类型:
会议/期刊
收录情况:
◇ SCIE
◇ CPCI(ISTP)
文章类型:
会议摘要
作者:
Zhou, Daobin[1]
*
;
Jin, Jie[2]
;
Fu, Zheng-zheng[3]
;
Yi, Shuhua[4]
;
Zhao, Wei Li[5]
;
Sun, Zimin[6]
;
Yang, Wei[7]
;
Li, Dengju[8]
;
Cui, Guohui[9]
;
Hu, Jianda[10]
;
Liu, Ting[11]
;
Song, Yongping[12]
;
Xu, Bing[13,14]
;
Zhu, Zunmin[15]
;
Xu, Wei[16]
;
Zhang, Mingzhi[17]
;
Tian, Yamin[18]
;
Zhu, Huaqiang[18]
;
Zhang, Bin[18]
;
Zhao, Renbin[18]
;
Zhang, Xiang-Yang[18]
;
单位:
[1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Hematol, Peking Union Med Coll Hosp, Beijing, Peoples R China
[2]Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Sch Med, Hangzhou, Peoples R China
浙江大学医学院附属第一医院
[3]Soochow Univ, Dept Hematol, Affiliated Hosp 1, Suzhou, Peoples R China
[4]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, Blood Dis Hosp & Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China
[5]Shanghai Rui Jin Hosp, Dept Hematol, Shanghai, Peoples R China
[6]Anhui Prov Hosp, Dept Hematol, Hefei, Peoples R China
[7]China Med Univ, Shengjing Hosp, Shenyang, Peoples R China
中国医科大学附属盛京医院
中国医科大学盛京医院
[8]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Peoples R China
内科学系
血液内科
华中科技大学同济医学院附属同济医院
[9]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Peoples R China
华中科技大学同济医学院附属协和医院
[10]Fujian Inst Hematol, Union Hosp, Dept Hematol, Fuzhou, Peoples R China
[11]Sichuan Univ, Dept Hematol, West China Hosp, Chengdu, Peoples R China
四川大学华西医院
[12]Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China
河南省肿瘤医院
[13]Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Peoples R China
[14]Xiamen Univ, Sch Med, Inst Hematol, Xiamen, Peoples R China
[15]Henan Prov Peoples Hosp, Inst Hematol, Zhengzhou, Peoples R China
[16]Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Hematol, Nanjing, Peoples R China
江苏省人民医院
[17]Inst Clin Med, Dept Oncol, Zhengzhou, Peoples R China
[18]Beijing InnoCare Pharma Tech Co Ltd, Beijing, Peoples R China
ISSN:
0006-4971
WOS:
WOS:000736398800046
中科院(CAS)分区:
出版当年[2020]版:
大类
|
1 区
医学
小类
|
1 区
血液学
最新[2025]版:
大类
|
1 区
医学
小类
|
1 区
血液学
JCR分区:
出版当年[2019]版:
Q1
HEMATOLOGY
影响因子:
21.1
最新[2023版]
19.2
最新五年平均
17.794
出版当年[2019版]
14.892
出版当年五年平均
16.601
出版前一年[2018版]
23.629
出版后一年[2020版]
第一作者:
Zhou, Daobin
第一作者单位:
[1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Hematol, Peking Union Med Coll Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Zhou Daobin,Jin Jie,Fu Zheng-zheng,et al.Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Waldenstrom's Macroglobulinemia Patients[J].BLOOD.2021,138:doi:10.1182/blood-2021-149350.
APA:
Zhou, Daobin,Jin, Jie,Fu, Zheng-zheng,Yi, Shuhua,Zhao, Wei Li...&Zhang, Xiang-Yang.(2021).Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Waldenstrom's Macroglobulinemia Patients.BLOOD,138,
MLA:
Zhou, Daobin,et al."Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Waldenstrom's Macroglobulinemia Patients".BLOOD 138.(2021)